Answers are grounded in this paper and cite their sources.
Observational analysis reduced symptoms in 10 patients with treatment-resistant schizophrenia, highlighting the effectiveness of a tailored approach.
Objectives Schizophrenia, a debilitating psychiatric disorder, often presents with chronic and treatment-resistant symptoms. While anti-psychotic medications remain the mainstay of treatment, a subset of patients remains refractory. Reasons for treatment resistance are multiple, ranging from neurobiological anatomical to genetic, socio-familial, and personal factors, lifestyle, and pharmacodynamic factors. Material and Methods A judicious mix of medication and graded modified electroconvulsive therapy (ECT) is mostly helpful and helps in mitigating symptoms. Here we will describe 10 cases of treatment-resistant schizophrenia, which responded to a specific tailored approach. Medication and ECT were helpful in offering a reduction of symptoms. Results All 10 cases were followed for 6 months, and it was seen that the patients who had received ECT during admission and who were on maintenance ECT showed a significant decrease in the positive and negative syndrome scale (PANSS) score and improvement in their day-to-day functioning. Conclusion A tailored-designed patient-specific protocol is desirable and effective.
No takes yet. Share an insight, caveat, or question.
Chauhan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: